Global Vascular Guidewires Market Overview:
The factors attributed to the high growth of the market are the increasing number of neurological disorders and the growing adoption of minimally invasive surgeries. Guidewires are an integral part of vascular intervention. They are utilized to access target vessels, cross lesions, and deliver definitive interventional therapy. Rising adoption of guidewires among specialist owing to procedural and technical benefits offered by nitinol materials used for manufacturing guidewires such as biocompatibility, recovering elongation, resistivity, steerability, and super elasticity.
- Increasing Prevalence of Cardiovascular Disorders
- Rising Adoption of Minimally Invasive Surgical Procedures Across Major Countries
- Rapid Technological Advancements in Guidewires
- High Cost of Guidewires
- Risks & Complications Associated with Guidewires
- Increase in Use of Nitinol in Vascular Guidewires
- Growth Opportunities in the Emerging Economies
- Dearth of Skilled Surgeons to Conduct Minimally Invasive Surgeries
- Availability of Effective Conventional Treatment Options
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are Abbott Laboratories (United States), Boston Scientific (United States), Cordis (United States), Cook Group (United States), Medtronic plc (Ireland), Terumo Corporation (Japan), ASAHI INTECC CO., LTD. (Japan), B. Braun Melsungen AG (Germany), Biotronik (Germany), Brosmed Medical (China), C.R. Bard Inc. (United States), GaltNeedleTech (United States), Gore Medical (United States) and Jotec (Germany). Additionally, following companies can also be profiled that are part of our coverage like Lepu Medical Technology (China), Merit Medical (United States) and OptiMed (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Vascular Guidewires market by 2026. Considering Market by Material, the sub-segment i.e. Nitinol will boost the Vascular Guidewires market. Considering Market by Coating, the sub-segment i.e. Coated will boost the Vascular Guidewires market. Considering Market by End User, the sub-segment i.e. Hospitals will boost the Vascular Guidewires market.
In Dec 2020, Rapid Medical, a company focused on the development of the first class of responsive, adjustable neurovascular devices, announces the FDA clearance of DRIVEWIRE, a novel guidewire with a steerable distal tip that handles complex anatomical turns with ease. This device is named Columbus outside of the United States.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Vascular Guidewires market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Vascular Guidewires market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planner, Vascular Guidewires Manufactures, Raw Material Suppliers, Government Regulatory and Research Organizations and End-Use Industries.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.